Trailing-twelve-month (TTM) revenue is $18.68 Billion with a year-over-year growth of +8.72%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $5,139,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-28 |
| Q4 FY2025Period ended 2025-12-31 | $4,259,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-11 |
| Q1 FY2026Period ended 2026-03-31 | $4,452,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-30 |
| Q2 FY2026Period ended 2026-06-30 | $4,832,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-28 |
| TTM revenue | $18,682,000,000 |
Current P/S: $61,765,308,500 market capitalization ÷ $18,682,000,000 TTM revenue = 3.31x.
Market capitalization source: FMP quote. Quote observed 2026-09-23T20:00:02.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $4.83B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-23T23:31:28.286Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Cruise Itinerary | $2.0B | $1.4B | $8.4B | $13.2B | $15.7B | $17.1B |
| Other Products And Services | $194M | $106M | $458M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Asia Pacific | $412M | $128M | $372M | $993M | $1.4B | $1.7B |
| Europe | $19M | $180M | $1.8B | $2.7B |
$18.68B
$18.68 Billion
+8.72%
vs. $17.18B a year ago (TTM)
+188.60%
5 Year compound annual growth rate
1 Year
+8.72%
3 Year
+15.88%
5 Year
+188.60%
10 Year
+8.26%
15 Year
+6.66%
20 Year
+6.84%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $17.93B | +$1.45B | +8.80% |
| 2024 | $16.48B | +$2.58B | +18.60% |
| 2023 | $13.90B | +$5.06B | +57.24% |
| 2022 | $8.84B | +$7.31B | +477.02% |
| 2021 | $1.53B | ($676.80M) | (30.64%) |
| 2020 |
TTM Growth
+8.72%
3-Year CAGR
+15.88%
5-Year CAGR
+188.60%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-23T23:31:28.286Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-11.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $788M |
| $864M |
| $3.0B |
| North America | $1.3B | $1.0B | $5.7B | $8.7B | $10.6B | $11.5B |
|---|
| Other Region | $242M | $78M | $540M | $847M | $1.0B | $862M |
|---|
| $2.21B |
| ($8.74B) |
| (79.83%) |
| 2019 | $10.95B | +$1.46B | +15.34% |
| 2018 | $9.49B | +$716.00M | +8.16% |
| 2017 | $8.78B | +$281.44M | +3.31% |
| 2016 | $8.50B | +$197.33M | +2.38% |
